- Attal, M., Harousseau, J.L., Stoppa, A.M., Sotto, J.J., Fuzibet, J.G., Rossi, J.F., Casassus, P., Maisonneuve, H., Facon, T., Ifrah, N., Payen, C. and Bataille, R. (1996) "A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome", N. Engl. J. Med. 335(2), 91-97.
- Alexanian, R. (1985) "Ten-year survival in multiple myeloma", Arch, Int. Med. 145, 2073-2074.
- KyIe, R.A. (1983) "Medical intelligence; long-term survival in multiple myeloma", N. Eng. J. Med.,314-316.
- Dutcher, J.P. and Wiernik, P.H. (1984) "Long-term survival of a patient with multiple myeloma-a cure?", Cancer 53, 2069-2072.
- Berenson, J.R., Lichtenstein, A., Porter, L., et al. (1996) "Efficacy of pamidronate in reducing the skeletal events in patients with advanced multiple myeloma", N. Engl. J. Med. 334, 488-493.
- Warrell, R.P. (1997) 'Gallium nitrate for the treatment of bone metastases", Cancer 80(8 Suppl.), 1680-1685.
- Warrell, R.P., Lovett, D., Dilmanian, F.A., Schneider, R. and Heelan, R. (1993) "Low-dose gallium nitrate for prevention of osteolysis in myeloma: results of a pilot randomized study", J Clin. Oncol. 11, 1-8.
- Lee, B.J., Lake-Lewin, D. and Myers, J.E. (1982) "Intensive treatment of multiple myeloma", In: Wiernik, P., ed Controversies in Oncology (Wiley, New York), pp 61-79.
- Case, D.C., Lee, B.J. and Clarkson, B.D. (1977) "Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, viacristine and BCNU: M-2 protocol", Am. J. Med. 63, 897-903.
- Niesvizky, R., Siegel, D. and Michaeli, J. (1993) "Biology and treatment of multiple myeloma", Blood Rev. 7, 24-33.
- Warrell, Jr., R.P., Bookman, R.S., Coonley, C.J., et al., (1984) "Gallium nitrate inhibits, calcium resorption from bone and is effective treatment for cancer-related hypercalcemia", J. Clin. Invest. 73, 1487-1490.
- Bockman, R.S., Repo, M.A., Warrell, Jr., R.P., et al., (1987) "Gallium nitrate inhibits bone resorption induced by recombinant human tumor necrosis factor (TNF)", Proc. Am. Assoc. Cancer Res. 28, 449. (abstr).
- Berenson, J., Lichtenstein, A., Porter, L., Bordoni, R., George, S., Lipton, A., Keller, A., Heffeman, M., Seaman, J. and Kight, R. (1995) "Long-term pamidronate disodium therapy leads to a reduction in skeletal related episodes (SRE) in stage III multiple myeloma patients and an improvement in survival in those on salvage therapy", Blood 86, 442a. (abstr).
- Savage, A.D., Belson, D.J., Vescio, R.A., et al. (1996) "Pamidronate reduces", Blood 88, 105a, (abstr).
Extended Survival in Advanced-Stage Multiple Myeloma Patients Treated with Gallium Nitrate
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.